[123I]ß-CIT and SPECT imaging

DRUG2 trials

Sponsors

Institute for Neurodegenerative Disorders

Conditions

Parkinson DiseaseParkinson's DiseaseParkinsonian Syndrome

Phase 2

Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease

CompletedNCT00096720

Institute for Neurodegenerative DisordersParkinson Disease, Parkinsonian Syndrome

Start: 2004-02-29End: 2007-05-31Updated: 2010-09-29

Study of Brain Imaging With Nuclear Technology in Individuals With Parkinsonian Syndrome

CompletedNCT00132626

Institute for Neurodegenerative DisordersParkinsonian Syndrome, Parkinson's Disease

Start: 1992-09-30End: 2005-08-31Target: 500Updated: 2019-04-03